Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bayer Gets EU Green Light to Market Jaydess Contraceptive-DJ


Wednesday, 5 Dec 2012 02:39am EST 

Dow Jones reported that Bayer AG has received the green light in Europe to market its new long-term contraceptive dubbed Jaydess. Health authorities in the European Union member states will grant national approvals soon. The product is likely to be launched in the European Union second quarter of 2013. Bayer SA has also submitted a marketing application in the United States for the new low dose levonorgestrel-releasing intrauterine system. 

Company Quote

95.41
-2.28 -2.33%
15 Aug 2014